Used as a key intermediate in the synthesis of pharmaceutical agents, particularly kinase inhibitors with potential anticancer activity. Its structure allows for selective substitution at multiple sites, making it valuable in drug discovery for modifying potency and selectivity. Commonly employed in the development of targeted therapies, especially those involving tyrosine kinase and EGFR inhibition. Also utilized in research settings to explore structure-activity relationships in quinazoline-based bioactive molecules.